[1]
S. Yıldırım, Özkan Alan, H. Şahika Yıldız, A. Doğan, S. Ay Ersoy, and H. Odabaş, “Prognostic impact of pan-immune-inflammation value and prognostic nutritional index in metastatic colorectal cancer patients treated with regorafenib”, Eur Res J, vol. 11, no. 6, pp. 1067–1077, Nov. 2025, doi: 10.18621/eurj.1768888.